Obesity startup Metsera is getting a new manufacturing partner and a new CEO.
On Tuesday, the well-funded startup announced that it would bring on specialty …
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
Survodutide, a novel glucagon/GLP-1 receptor dual agonist, improved metabolic dysfunction-associated steatohepatitis (MASH) with no worsening of fibrosis, according to results of a phase II trial.
Los Angeles podiatrist and social media personality Dana Brems, DPM, has charged in an Instagram post that a company used AI to make a fake
The National Agricultural Research and Development Institute (NARDI) in Fundulea, Romania, relies on electronic multichannel pipettes from INTEGRA Biosciences to streamline its liquid handling workflows.